Jernbehandling av Crohns sykdom
- Prosjektnummer
- 19917
- Ansvarlig person
- Kari Erichsen
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Forskerutdanning - dr.grad
- Helsekategori
- Gastroenterology & Hepatology
- Forskningsaktivitet
- Klinisk forskning
Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis.
Inflamm Bowel Dis 2005 Aug;11(8):744-8.
PMID: 16043990
Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease.
Scand J Gastroenterol 2005 Sep;40(9):1058-65.
PMID: 16165718
Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease.
Aliment Pharmacol Ther 2005 Nov;22(9):831-8.
PMID: 16225492
Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease.
Scand J Gastroenterol 2003 May;38(5):543-8.
PMID: 12795468
Oral versus intravenous iron therapy in patients with inflammatory bowel disease
UEGW Praha 2004, Gut 2004; 53 (Suppl VI)TUE-G-341
Calprotectin in faeces and gut lavage fluid; relationship to intestinal permeability and disease activity in IBD
Nordic Meeting of Gastroenterology 2004, Scand J Gastroenterol 2004; 39 (Suppl 240) Or 8
Effect of ferrous fumarate supplementation in dextran sulfate sodium colitis in rats
Gut 2003; 52 (Suppl VI) A28
Iron therapy in inflammatory bowel disease : effects on oxidative stress and disease activity
- Disputert:
- desember 2005
- Hovedveileder:
- Trygve Hausken
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest